Review
Bone Marrow Transplantation (2008) 41, 127–132; doi:10.1038/sj.bmt.1705960; published online 17 December 2007
Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome
- 1Hematology Department, Eurocord Hôpital, Saint Louis, Paris, France
- 2Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA
Correspondence: Professor E Gluckman, Service de Greffe Moelle, Hopital St Louis, Eurocord, 1 avenue Claude Vellefaux, 75475 Paris cedex 10, France. E-mail: eliane.gluckman@sls.aphp.fr
Received 6 September 2007; Revised 8 November 2007; Accepted 9 November 2007; Published online 17 December 2007.
Abstract
Aplastic anemia is a rare disease in children that is most commonly idiopathic and less often a hereditary disorder. Hereditary bone marrow failure (BMF) syndromes, however, should be considered both in children and in adults before any attempt at treatment. Precise diagnosis is important because it will modify prognostic treatment options and the results of bone marrow transplantation. In this review, we will report recent results of treatment of Fanconi anemia and other hereditary BMF syndromes.
Keywords:
aplastic anemia, hematopoietic stem cell transplant, Fanconi anemia
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
HSCT for Fanconi anemia in children: factors that influence early and late results
Bone Marrow Transplantation Review
RESEARCH
Journal of Cerebral Blood Flow & Metabolism Original Article
Bone Marrow Transplantation Original Article
Fanconi anaemia: new strategies
Bone Marrow Transplantation Original Article
Bone Marrow Transplantation Original Article

